Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
Go back to Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021| Merck & Co. (NYSE: MRK) | Delayed: 120.60 +1.00 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.60 | 52 Week High | $65.46 | |||
| Open | $120.90 | 52 Week Low | $47.97 | |||
| Day High | $121.81 | P/E | 82.04 | |||
| Day Low | $119.51 | EPS | $1.47 | |||
| Volume | 10,478,095 | |||||
| (NYSE: OGN) | Delayed: 13.48 +0.03 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.45 | 52 Week High | $8.00 | |||
| Open | $13.46 | 52 Week Low | $8.00 | |||
| Day High | $13.48 | P/E | N/A | |||
| Day Low | $13.44 | EPS | $0.00 | |||
| Volume | 3,133,163 | |||||
